Seventy-six percent of workers older than 60 years of age are overweight or obese. However, less than one third of those 40 years of age and younger suffer these health issues. This is one of the conclusions shown in the research of Alberto Cordero of the School of Medicine, and the University Hospital.
Researchers at SUNY Downstate Medical Center have developed a substance that inhibits the progress of multiple sclerosis (MS) in an animal model. The agent, a novel calpain inhibitor, can be administered orally.
The Crohn’s & Colitis Foundation of America (CCFA) and ConvaTec, a world-leading manufacturer of ostomy and wound care products, announced today the recipients of the Great Comebacks(R) Program 2006 Ina Brudnick Scholarship and the Comeback Kids awards. Abby Ryan, the 2006 Ina Brudnick Scholar, was honored alongside Lauren Belanger, Becca Davis and Michelle Flude, the 2006 Comeback Kids, in New York City on November 18th at CCFA’s annual meeting.
The deadline to submit nominations for the 2007 Welcome Back Awards, a national awards program that recognizes heroes of the depression community, has been extended by one month. Nominations are now due by Sunday, December 31, 2006.
Novartis announced today that it has been awarded a contract valued at USD 40.95 million to supply to the US government a pre-pandemic influenza vaccine* against the H5N1 avian influenza strain. Global health authorities have identified H5N1 as an influenza strain with pandemic potential.
A powerful analysis from this month’s Vaccine highlights the huge gap between current vaccination coverage across Europe and the recommendations endorsed by the European U nion. Currently, only one-third of all high-risk populations are receiving seasonal influenza vaccine in Europe, resulting in avoidable morbidity, hospitalizations and mortality.
Ageing in the community is one of the primary concerns that needs be addressed in elderly care policy, Secretary for Health, Welfare & Food Dr York Chow says.
A new therapeutic method using human antibodies to neutralize toxins was found to prevent Clostridium difficile-induced de ath in hamsters say researchers from New Jersey and Massachusetts. They report their findings in the November 2006 issue of the journal Infection and Immunity.
Results of a new analysis showed that patients who have heart disease and chronic kidney disease who took Lipitor? (atorvastatin calcium) Tablets (80 mg) reduced their risk of heart attack and stroke by 32 percent compared with patients taking the 10 mg dose of Lipitor. This analysis of a subset of patients from the five-year TNT (Treating to New Targets) study was designed and completed after the end of the trial. The data were presented here today at the Annual Scientific Sessions of the American Heart Association.
Novartis announced today a positive opinion supporting European Union approval of Exforge? (valsartan/ amlodipine besylate) as a new treatment option for patients with high blood pressure.